Cargando…

CNST is Characteristic of Leukemia Stem Cells and is Associated With Poor Prognosis in AML

Consortin (CNST) is a protein located on the trans-Golgi network that can target transmembrane proteins to the plasma membrane. Although CNST was discovered more than 10 years ago, there are still not enough studies on its function. During our search for possible new acute myeloid leukemia (AML) mar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Haoyu, Zhang, Xu, Zhao, Ziyan, Zhu, Hongying, Li, Danyang, Yang, Yang, Zhao, Wenbo, Zhang, Fei, Wang, Yuefeng, Zhu, Lina, Ding, Zewen, Li, Xiangzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157791/ https://www.ncbi.nlm.nih.gov/pubmed/35662693 http://dx.doi.org/10.3389/fphar.2022.888243

Ejemplares similares

MOF negatively regulates estrogen receptor α signaling via CUL4B-mediated protein degradation in breast cancer
por: Zhang, Xu, et al.
Publicado: (2022)

Blocking circ-CNST suppresses malignant behaviors of osteosarcoma cells and inhibits glycolysis through circ-CNST-miR-578-LDHA/PDK1 ceRNA networks
por: Hu, Rui, et al.
Publicado: (2021)

Circular RNA_CNST Promotes the Tumorigenesis of Osteosarcoma Cells by Sponging miR-421
por: Wang, Ji-Hai, et al.
Publicado: (2020)

Chidamide-based 3-drug combination regimen reverses molecular relapse post transplantation in AML1-ETO–positive acute myeloid leukemia
por: Xi, Yang, et al.
Publicado: (2023)

MOF Regulates TNK2 Transcription Expression to Promote Cell Proliferation in Thyroid Cancer
por: Li, Danyang, et al.
Publicado: (2020)

Increased NFATC4 Correlates With Poor Prognosis of AML Through Recruiting Regulatory T Cells
por: Zhao, Chong, et al.
Publicado: (2020)

Validated Instruments of Quality of Life (QOL) in Patients With Acute Myeloid Leukemia (AML) and Other Cancers
por: Salas, Maribel, et al.
Publicado: (2020)

Aberrant Scinderin Expression Correlates With Liver Metastasis and Poor Prognosis in Colorectal Cancer
por: Lin, Qi, et al.
Publicado: (2019)

High FAAP24 expression reveals poor prognosis and an immunosuppressive microenvironment shaping in AML
por: Bao, Xiebing, et al.
Publicado: (2023)

Elevated Serum Uric Acid is Associated With Poor Survival in Advanced HCC Patients and Febuxostat Improves Prognosis in HCC Rats
por: Wu, Le, et al.
Publicado: (2021)

High expression of phosphorylated focal adhesion kinase predicts a poor prognosis in human colorectal cancer
por: Yu, Guanyu, et al.
Publicado: (2022)

DHX15 is associated with poor prognosis in acute myeloid leukemia (AML) and regulates cell apoptosis via the NF-kB signaling pathway
por: Pan, Lili, et al.
Publicado: (2017)

MicroRNA–mRNA Pairs Associated with Outcome in AML: From In Vitro Cell-Based Studies to AML Patients
por: Bhise, Neha S., et al.
Publicado: (2016)

High Expression of RAI14 in Triple-Negative Breast Cancer Participates in Immune Recruitment and Implies Poor Prognosis Through Bioinformatics Analyses
por: Cui, Ranliang, et al.
Publicado: (2022)

Lack of MOF Decreases Susceptibility to Hypoxia and Promotes Multidrug Resistance in Hepatocellular Carcinoma via HIF-1α
por: Wang, Meng, et al.
Publicado: (2021)

IQGAP3 Overexpression Correlates With Poor Prognosis and Radiation Therapy Resistance in Breast Cancer
por: Hua, Xin, et al.
Publicado: (2021)

Low Expression of Pseudogene POU5F1B Affects Diagnosis and Prognosis in Acute Myeloid Leukemia (AML)
por: Yi, Jing, et al.
Publicado: (2019)

VRK1 Predicts Poor Prognosis and Promotes Bladder Cancer Growth and Metastasis In Vitro and In Vivo
por: Wu, Jiacheng, et al.
Publicado: (2022)

Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient
por: Nielsen, Torsten H., et al.
Publicado: (2013)

Identification of novel immune-related molecular subtypes and a prognosis model to predict thyroid cancer prognosis and drug resistance
por: Zhang, Wei, et al.
Publicado: (2023)

Tyrosine Phosphatase PTPRO Deficiency in ERBB2-Positive Breast Cancer Contributes to Poor Prognosis and Lapatinib Resistance
por: Dong, Hongmei, et al.
Publicado: (2022)

Does aberrant membrane transport contribute to poor outcome in adult acute myeloid leukemia?
por: Chigaev, Alexandre
Publicado: (2015)

Transcriptome-Based Co-Expression of BRD4 and PD-1/PD-L1 Predicts Poor Overall Survival in Patients With Acute Myeloid Leukemia
por: Chen, Cunte, et al.
Publicado: (2021)

NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma
por: Huang, Zhen, et al.
Publicado: (2021)

Association Between Obesity and Poor Prognosis in Patients Receiving Anlotinib for Advanced Non-Small Cell Lung Cancer
por: Xiong, Anning, et al.
Publicado: (2022)

Cantharidin Induces Apoptosis and Promotes Differentiation of AML Cells Through Nuclear Receptor Nur77-Mediated Signaling Pathway
por: Yu, Zanyang, et al.
Publicado: (2020)

Lowering Etoposide Doses Shifts Cell Demise From Caspase-Dependent to Differentiation and Caspase-3-Independent Apoptosis via DNA Damage Response, Inducing AML Culture Extinction
por: Bruni, Emanuele, et al.
Publicado: (2018)

ELMO1 Is Upregulated in AML CD34+ Stem/Progenitor Cells, Mediates Chemotaxis and Predicts Poor Prognosis in Normal Karyotype AML
por: Capala, Marta E., et al.
Publicado: (2014)

Association of genetic polymorphisms in genes involved in Ara-C and dNTP metabolism pathway with chemosensitivity and prognosis of adult acute myeloid leukemia (AML)
por: Zhu, Ke-Wei, et al.
Publicado: (2018)

Corrigendum: NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma
por: Huang, Zhen, et al.
Publicado: (2021)

Biomodulatory Treatment With Azacitidine, All-trans Retinoic Acid and Pioglitazone Induces Differentiation of Primary AML Blasts Into Neutrophil Like Cells Capable of ROS Production and Phagocytosis
por: Klobuch, Sebastian, et al.
Publicado: (2018)

Application of iron oxide nanoparticles in the diagnosis and treatment of leukemia
por: Wang, Yiling, et al.
Publicado: (2023)

Low Hematocrit Is a Strong Predictor of Poor Prognosis in Lung Cancer Patients
por: Zhang, Xin, et al.
Publicado: (2018)

The Top 100 Highly Cited Original Articles on Immunotherapy for Childhood Leukemia
por: Zhong, Qing, et al.
Publicado: (2019)

The pyroptosis-related gene signature predicts prognosis and reveals characterization of the tumor immune microenvironment in acute myeloid leukemia
por: Zhou, Tao, et al.
Publicado: (2022)

Acute myeloid leukemia (AML)‐derived mesenchymal stem cells induce chemoresistance and epithelial–mesenchymal transition‐like program in AML through IL‐6/JAK2/STAT3 signaling
por: Lu, Jianle, et al.
Publicado: (2023)

A Predictor Combining Clinical and Genetic Factors for AML1-ETO Leukemia Patients
por: Yang, Min, et al.
Publicado: (2022)

A mechanistic review of chinese medicine polyphenols on bone formation and resorption
por: Li, Yan, et al.
Publicado: (2022)

Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology
por: Ma, Chao, et al.
Publicado: (2023)

Impact of CNA on AML prognosis
por: Gonzales, Fanny, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m2ckosgmg914aut2m8dqnk68oh